Skip to main content
Medical information Clinical review pending

Genetic Testing

Nipah Virus RNA Detection Qualitative Test

Detects the presence of the Nipah virus RNA, which causes severe respiratory illness and neurological complications. This test uses Real Time PCR technology.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Whole blood, serum, plasma, respiratory secretions (e.g., nasal/throat swabs, sputum), or urine. Confirm specific sample type required with the laboratory before booking.
Results
Typically 5-7 days. Confirm exact turnaround time with the laboratory before booking.
Preparation
No specific patient preparation is required. Inform the laboratory about any relevant clinical history or recent exposures.
Test priceKSh 15,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Nipah Virus RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected Nipah virus infection based on symptoms (fever, respiratory distress, neurological symptoms).
  • ✓Exposure to known Nipah virus cases or infected animals (e.g., bats, pigs).
  • ✓Travel history to areas with Nipah virus outbreaks.
  • ✓Public health surveillance during outbreaks.
  • ✓Differential diagnosis of severe febrile illness with respiratory or neurological involvement.
02

In plain language

What this test helps you understand

This test is used to confirm or rule out an active Nipah virus infection in individuals presenting with relevant symptoms or exposure history. Early detection is crucial for patient management and public health measures.
The Nipah Virus RNA Detection Qualitative Test is a diagnostic tool used to identify the Nipah virus in patients. This virus can cause severe respiratory illness and neurological complications. Early detection is important for managing the infection and preventing its spread.

This test specifically looks for the genetic material (RNA) of the Nipah virus. It uses a technique called Real Time PCR, which is highly sensitive and accurate. The test can be performed on various samples, including whole blood, serum, plasma, respiratory secretions, and urine.

Individuals experiencing symptoms like fever, respiratory distress, or neurological changes, especially after potential exposure to infected animals or people, may need this test. People living in or travelling to areas with known Nipah virus activity should also consider testing if they develop symptoms.

Taking this test allows for early diagnosis, enabling prompt medical care. It also helps public health officials track and control the spread of the virus. Results are typically available within 5-7 days. A positive result indicates the presence of the virus, requiring further medical evaluation. A negative result suggests the virus was not detected in the sample at the time of testing.

We have branches in major cities across Kenya. Contact us at +254711564616 to book your test. Please ensure you sign the consent form and provide relevant medical history.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Inform the laboratory about any relevant clinical history or recent exposures.
SampleWhole blood, serum, plasma, respiratory secretions (e.g., nasal/throat swabs, sputum), or urine. Confirm specific sample type required with the laboratory before booking.
MethodologyReal Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of viral RNA, indicating an active infection. It cannot determine the severity of the illness or predict long-term outcomes. False negatives may occur if the sample is collected too early or late in the infection, or if the viral load is very low. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Nipah virus is a zoonotic virus (transmitted from animals to humans) that can cause severe illness, including respiratory problems and brain inflammation (encephalitis).
It is often spread through contact with infected animals, particularly bats and pigs, or through contaminated food. Human-to-human transmission can also occur.
Symptoms can range from mild to severe and include fever, headache, muscle pain, vomiting, sore throat, and difficulty breathing. Severe cases can lead to confusion, seizures, and coma.
There is no specific antiviral treatment for Nipah virus infection. Management focuses on supportive care, such as managing respiratory distress and providing intensive care.
The Real Time PCR test used is highly accurate for detecting the virus RNA when present in the sample. However, results should always be interpreted in the context of the patient's clinical presentation.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp